Standout Papers

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, p... 2017 2026 2020 2023 356
  1. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial (2017)
    Martin Alberer, Ulrike Gnad-Vogt et al. The Lancet

Immediate Impact

39 by Nobel laureates 8 from Science/Nature 91 standout
Sub-graph 1 of 21

Citing Papers

Endosomal escape: A bottleneck for LNP-mediated therapeutics
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
4 intermediate papers

Works of Martin Alberer being referenced

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
2017 Standout

Author Peers

Author Last Decade Papers Cites
Martin Alberer 384 150 196 277 218 45 959
Mary Allen 304 126 215 193 67 57 1.0k
Serena Marchi 399 103 398 131 169 59 983
R. Berger 210 44 741 89 70 44 1.1k
Dhanraj Samuel 187 33 389 219 53 51 962
Brandon Essink 590 68 375 207 25 35 997
Frederick C. Robbins 361 41 511 86 111 60 1.1k
Eli Gold 282 68 668 76 105 35 1.0k
S. G. Anderson 192 179 170 173 72 48 1.1k
Benjamin Lee 439 37 351 122 59 42 1.0k
R. Ward 437 74 383 83 43 27 1.1k

All Works

Loading papers...

Rankless by CCL
2026